Logo image of ACGLN

ARCH CAPITAL GROUP LTD - ACGL 4.55 PERP (ACGLN) Stock Fundamental Analysis

NASDAQ:ACGLN - Nasdaq - US03939A4040 - Currency: USD

17.25  +0.13 (+0.76%)

After market: 16.75 -0.5 (-2.9%)

Fundamental Rating

6

ACGLN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. While ACGLN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ACGLN is valued quite cheap, while showing a decent growth score. This is a good combination! ACGLN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ACGLN had positive earnings in the past year.
In the past year ACGLN had a positive cash flow from operations.
ACGLN had positive earnings in each of the past 5 years.
In the past 5 years ACGLN always reported a positive cash flow from operatings.
ACGLN Yearly Net Income VS EBIT VS OCF VS FCFACGLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 6.02%, ACGLN belongs to the top of the industry, outperforming 88.81% of the companies in the same industry.
ACGLN's Return On Equity of 20.52% is amongst the best of the industry. ACGLN outperforms 83.92% of its industry peers.
ACGLN's Return On Invested Capital of 4.43% is fine compared to the rest of the industry. ACGLN outperforms 76.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACGLN is in line with the industry average of 4.47%.
The last Return On Invested Capital (4.43%) for ACGLN is above the 3 year average (3.89%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.02%
ROE 20.52%
ROIC 4.43%
ROA(3y)5.5%
ROA(5y)4.86%
ROE(3y)18.54%
ROE(5y)16.3%
ROIC(3y)3.89%
ROIC(5y)3.58%
ACGLN Yearly ROA, ROE, ROICACGLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ACGLN's Profit Margin of 25.42% is amongst the best of the industry. ACGLN outperforms 94.41% of its industry peers.
In the last couple of years the Profit Margin of ACGLN has grown nicely.
The Operating Margin of ACGLN (23.55%) is better than 86.01% of its industry peers.
In the last couple of years the Operating Margin of ACGLN has declined.
Industry RankSector Rank
OM 23.55%
PM (TTM) 25.42%
GM N/A
OM growth 3Y4.67%
OM growth 5Y-2.93%
PM growth 3Y2.45%
PM growth 5Y1.58%
GM growth 3YN/A
GM growth 5YN/A
ACGLN Yearly Profit, Operating, Gross MarginsACGLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACGLN is destroying value.
The number of shares outstanding for ACGLN has been increased compared to 1 year ago.
Compared to 5 years ago, ACGLN has less shares outstanding
The debt/assets ratio for ACGLN has been reduced compared to a year ago.
ACGLN Yearly Shares OutstandingACGLN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
ACGLN Yearly Total Debt VS Total AssetsACGLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

ACGLN has a debt to FCF ratio of 0.41. This is a very positive value and a sign of high solvency as it would only need 0.41 years to pay back of all of its debts.
ACGLN has a Debt to FCF ratio of 0.41. This is amongst the best in the industry. ACGLN outperforms 84.62% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that ACGLN is not too dependend on debt financing.
ACGLN has a Debt to Equity ratio of 0.13. This is in the better half of the industry: ACGLN outperforms 78.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.41
Altman-Z N/A
ROIC/WACC0.59
WACC7.45%
ACGLN Yearly LT Debt VS Equity VS FCFACGLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ACGLN Yearly Current Assets VS Current LiabilitesACGLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.70% over the past year.
Measured over the past years, ACGLN shows a very strong growth in Earnings Per Share. The EPS has been growing by 26.96% on average per year.
ACGLN shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.08%.
Measured over the past years, ACGLN shows a quite strong growth in Revenue. The Revenue has been growing by 19.89% on average per year.
EPS 1Y (TTM)9.7%
EPS 3Y37.06%
EPS 5Y26.96%
EPS Q2Q%-9.24%
Revenue 1Y (TTM)27.08%
Revenue growth 3Y23.81%
Revenue growth 5Y19.89%
Sales Q2Q%17.11%

3.2 Future

ACGLN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.29% yearly.
ACGLN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.01% yearly.
EPS Next Y-14.78%
EPS Next 2Y2.2%
EPS Next 3Y3.29%
EPS Next 5YN/A
Revenue Next Year11.53%
Revenue Next 2Y9.39%
Revenue Next 3Y7.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACGLN Yearly Revenue VS EstimatesACGLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
ACGLN Yearly EPS VS EstimatesACGLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

ACGLN is valuated cheaply with a Price/Earnings ratio of 1.86.
Compared to the rest of the industry, the Price/Earnings ratio of ACGLN indicates a rather cheap valuation: ACGLN is cheaper than 88.11% of the companies listed in the same industry.
ACGLN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.92.
With a Price/Forward Earnings ratio of 2.18, the valuation of ACGLN can be described as very cheap.
ACGLN's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACGLN is cheaper than 86.71% of the companies in the same industry.
ACGLN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.65.
Industry RankSector Rank
PE 1.86
Fwd PE 2.18
ACGLN Price Earnings VS Forward Price EarningsACGLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ACGLN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACGLN is cheaper than 93.71% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ACGLN is valued cheaply inside the industry as 91.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.98
EV/EBITDA 1.95
ACGLN Per share dataACGLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ACGLN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2Y2.2%
EPS Next 3Y3.29%

7

5. Dividend

5.1 Amount

ACGLN has a Yearly Dividend Yield of 6.79%, which is a nice return.
Compared to an average industry Dividend Yield of 3.28, ACGLN pays a better dividend. On top of this ACGLN pays more dividend than 92.31% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.51, ACGLN pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.79%

5.2 History

On average, the dividend of ACGLN grows each year by 118.11%, which is quite nice.
ACGLN has been paying a dividend for over 5 years, so it has already some track record.
ACGLN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)118.11%
Div Incr Years0
Div Non Decr Years3
ACGLN Yearly Dividends per shareACGLN Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

ACGLN pays out 44.62% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ACGLN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP44.62%
EPS Next 2Y2.2%
EPS Next 3Y3.29%
ACGLN Yearly Income VS Free CF VS DividendACGLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
ACGLN Dividend Payout.ACGLN Dividend Payout, showing the Payout Ratio.ACGLN Dividend Payout.PayoutRetained Earnings

ARCH CAPITAL GROUP LTD - ACGL 4.55 PERP

NASDAQ:ACGLN (4/24/2025, 8:00:00 PM)

After market: 16.75 -0.5 (-2.9%)

17.25

+0.13 (+0.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners91.35%
Inst Owner ChangeN/A
Ins Owners3.1%
Ins Owner ChangeN/A
Market Cap6.48B
Analysts80.87
Price Target21.14 (22.55%)
Short Float %0.01%
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield 6.79%
Yearly Dividend5.08
Dividend Growth(5Y)118.11%
DP44.62%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-14 2025-03-14 (0.284375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.58%
Min EPS beat(2)-0.36%
Max EPS beat(2)21.52%
EPS beat(4)3
Avg EPS beat(4)12.44%
Min EPS beat(4)-0.36%
Max EPS beat(4)21.52%
EPS beat(8)7
Avg EPS beat(8)18.38%
EPS beat(12)11
Avg EPS beat(12)24.08%
EPS beat(16)15
Avg EPS beat(16)28.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-4.29%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-6.09%
Max Revenue beat(4)4.53%
Revenue beat(8)6
Avg Revenue beat(8)1.08%
Revenue beat(12)7
Avg Revenue beat(12)-0.54%
Revenue beat(16)9
Avg Revenue beat(16)0.84%
PT rev (1m)-10.92%
PT rev (3m)-14.23%
EPS NQ rev (1m)-8.45%
EPS NQ rev (3m)-45.52%
EPS NY rev (1m)-1.26%
EPS NY rev (3m)-13.98%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 1.86
Fwd PE 2.18
P/S 0.39
P/FCF 0.98
P/OCF 0.97
P/B 0.31
P/tB 0.33
EV/EBITDA 1.95
EPS(TTM)9.27
EY53.74%
EPS(NY)7.9
Fwd EY45.8%
FCF(TTM)17.62
FCFY102.17%
OCF(TTM)17.76
OCFY102.96%
SpS44.72
BVpS55.41
TBVpS51.82
PEG (NY)N/A
PEG (5Y)0.07
Profitability
Industry RankSector Rank
ROA 6.02%
ROE 20.52%
ROCE 5.61%
ROIC 4.43%
ROICexc 4.49%
ROICexgc 6.02%
OM 23.55%
PM (TTM) 25.42%
GM N/A
FCFM 39.41%
ROA(3y)5.5%
ROA(5y)4.86%
ROE(3y)18.54%
ROE(5y)16.3%
ROIC(3y)3.89%
ROIC(5y)3.58%
ROICexc(3y)3.95%
ROICexc(5y)3.65%
ROICexgc(3y)5.27%
ROICexgc(5y)4.8%
ROCE(3y)4.92%
ROCE(5y)4.54%
ROICexcg growth 3Y12.01%
ROICexcg growth 5Y3.19%
ROICexc growth 3Y11.28%
ROICexc growth 5Y2.52%
OM growth 3Y4.67%
OM growth 5Y-2.93%
PM growth 3Y2.45%
PM growth 5Y1.58%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.41
Debt/EBITDA 0.65
Cap/Depr 21.7%
Cap/Sales 0.3%
Interest Coverage 31.16
Cash Conversion 159.18%
Profit Quality 155.01%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.45%
ROIC/WACC0.59
Cap/Depr(3y)41.7%
Cap/Depr(5y)46.55%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.43%
Profit Quality(3y)182.15%
Profit Quality(5y)183.38%
High Growth Momentum
Growth
EPS 1Y (TTM)9.7%
EPS 3Y37.06%
EPS 5Y26.96%
EPS Q2Q%-9.24%
EPS Next Y-14.78%
EPS Next 2Y2.2%
EPS Next 3Y3.29%
EPS Next 5YN/A
Revenue 1Y (TTM)27.08%
Revenue growth 3Y23.81%
Revenue growth 5Y19.89%
Sales Q2Q%17.11%
Revenue Next Year11.53%
Revenue Next 2Y9.39%
Revenue Next 3Y7.01%
Revenue Next 5YN/A
EBIT growth 1Y24.98%
EBIT growth 3Y29.6%
EBIT growth 5Y16.38%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.24%
FCF growth 3Y25.05%
FCF growth 5Y26.92%
OCF growth 1Y16.07%
OCF growth 3Y24.87%
OCF growth 5Y26.64%